Additionally, we performed GSEA for the comparison of PDΔATRX models with five non-MYCN amplified neuroblastoma cell lines (S8E Fig, for number of DEGs see S2 Table) and for the comparison of neuroblastoma tumors from the individualized THERapy (iTHER) project. This evidence concerns the gene MYCN and neuroblastoma.